According to a new market report published by Transparency Market Research Healthcare CMO Market [Pharmaceutical Contract Manufacturing (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Formulations (FDF) Manufacturing and Packaging) & Medical Device Contract Manufacturing (Design Outsourcing, Device Manufacturing & Final Goods Assembly)]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019, the global healthcare CMO market was valued at USD 97.66 billion in 2012 and is estimated to reach market worth USD 246.50 billion in 2019 at a CAGR of 14.3% from 2013 to 2019.

Initially, the paradigm of most of the pharmaceutical companies was vertically integrated i.e. the company itself performed all the operations required for its business. Eventually, some of the factors such as rising cost pressures, increased pressure from regulatory agencies, cost benefits and pharmaceutical companies’ desire to focus on their core competencies such as R&D and marketing have created an intense need for outsourcing their manufacturing activities and stimulated the global pharmaceutical and medical device contract manufacturing market. In addition, reduced government healthcare spending, increasing government deficits in developed nations and growing competition in medical device industry has forced many pharmaceutical and medical device companies to recalibrate their business strategies and investigate new efficiencies in product design, development, manufacturing and marketing of products.

Browse the full Healthcare CMO Market report at http://www.transparencymarketresearch.com/healthcare-cmo-market.html


Moreover, rising number of patients undergoing medical surgical procedures, expiration of blockbuster drugs, increasing disease incidences coupled with increased preference for innovative treatment therapies further propels the demand for pharmaceutical and medical device contract manufacturing services. The strategic outsourcing approach is aiding the biotech and pharmaceutical companies to focus on their core strategies and utilize their internal resources for more critical in-house projects.

The market for contract pharmaceutical manufacturing services accounts for the largest share of the overall healthcare CMO market (55.4% in 2012). Based on type of services provided by contract manufacturers, the segment is further classified into API manufacturing, FDF manufacturing and packaging. Among these, the market for contract API manufacturing accounts for the largest share in 2012. However, the market for contract FDF manufacturing is growing at an attractive growth rate i.e. 16.8% during the forecast period of 2013 to 2019 due to growing demand for generic products and large number of patent expirations of blockbuster drugs. In addition, companies do not have in-house resources, expertise and all the technologies required for manufacturing various final dosage formulations and hence, outsourcing serves to be more cost effective solution for pharmaceutical companies.

Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/healthcare-cmo-market.htm

The medical device contract manufacturing market has also witnessed a significant growth in the past decade. This growth has been attributed towards rising demand for R&D activities, structural changes in the healthcare system and reduced government spending towards healthcare budget. Medical device contract manufacturers are now offering various services including design outsourcing, device manufacturing and final goods assembly. The market for device manufacturing segment was accounted to have the largest market share in 2012 (87.7%) and is expected to grow at an attractive growth rate during the forecast period of 2013 to 2019.

Geographically, North America accounted for the largest share of the global pharmaceutical outsourcing services market in 2012 followed by Asia-Pacific. The Asia-Pacific region is expected to represent the highest growth rate (17.8% for the period 2013 to 2019) owing to the availability of trained resources, low cost labor, favorable regulatory policies and establishment of large number of contract manufacturing plants of various companies. Increased compliance by companies regarding manufacturing and quality standards of the U.S. Food and Drug Administration (FDA) and EMEA requirements to further boost the market.

The major players of this market include Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc., Greatbatch, Inc., Memry Corporation, Teleflex MedOEM, Admedes Schuessler, Donatelle and others.

 
The global healthcare CMO market is segmented as follows:

Global Healthcare CMO Market, by Service Type
Pharmaceutical Contract Manufacturing Services
APIs (Active Pharmaceutical Ingredients) Manufacturing
FDF (Finished Dosage Formulation) Development and Manufacturing
Solid Dosage Formulations
Semi-solid and Liquid Dose Formulations
Injectable Dose Formulations
Packaging
Medical Device Contract Manufacturing Services
Design Outsourcing
Device Manufacturing
Material Processing Services
Electronic Manufacturing Services
Finished Products
Final Goods Assembly
Global Healthcare CMO Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (ROW)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2452


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.